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A high-performance liquid chromatographic procedure is presented for the determination of hydrochlorothiazide (HCT) and enalapril maleate (EM) in pharmaceutical tablets. An aliquot of the
sample is dissolved in 15% acetonitrile (ACN) containing thiophylline as an internal standard and chromatographed on a Supelcosil LC-8 (5 µm), (150 mm × 4.6 mm i.d.) column. The mobile phase was 3.0
mM tetrabutylammoniumhydrogen sulfate (TBAHS) in ACN/water/triethylamine (TEA), (14, 85.6, 6.4
V/V) adjusted to pH 4.1 by glacial acetic acid. The detection was at 220 nm. The method was tested
for linearity, accuracy, recovery, and specificity.
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Introduction
Hydrochlorothiazide (HCT) is a thiazide diuretic which reduces the resorption of electrolytes and consequently of water. Enalapril maleate (EM) is a derivative of 2 amino acids, L-alanine and L-proline, and is
an antihypertensive and a vasodilator in congestive heart failure. The 2 drugs are used in association in the
treatment of hypertension1 .
Several methods are available in the literature for the determination of HCT and EM. Most of these
methods are for the determination of either HCT or EM separately. For instance, HCT has been determined
in urine samples and tablet formulation by HPLC2−3 and by non-aqueous titration4 . Enalapril maleate
has been analyzed in pharmaceutical combinations containing 0.5-0.1% methylcellulose by extraction to
acetonitrile and injecting the extracts to HPLC5 . However, few methods are present in the literature for the
simultaneous determination of EM and HCT. Enalapril maleate and HCT were determined simultaneously in
pharmaceutical tablets using first-derivative ultraviolet spectrophotometry, with zero-crossing and peak-tobase measurement methods6 and by HPLC with either programmable UV-detectors at 2 different wavelengths
or with electrochemical detection6−7 . In many cases, the direct UV/VIS methods lack specificity, because
many compounds my absorb in the UV region and they will interfere if they are not separated. Other
methods described in the literature6−7 are based upon the use of either a programmable UV-detector or
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the use of electrochemical detectors which are sophisticated, or not readily available detectors. This paper
describes a reversed-phase HPLC method for the simultaneous determination of HCT and EM in commercial
tablets. The method is specific and simple. The method was applied successfully to commercial products and
proved to be free of interference from excipients normally used in tablet formulation. It was also validated
for precision and accuracy.

Experimental
Apparatus
The apparatus employed was a Du Pont 8800 pump equipped with a 10-µL manual Rheodyne loop-injector,
a Du Pont UV variable wavelength detector, and a Spectra-Physics (SP-4100) integrator. A reversed-phase
Supelcosil LC-8 (5µ), (150 mm × 4.6 mm i.d.) column was used.

Chemicals
Generally, all chemicals used were the purest grade available and were used as received without further purification. Acetonitrile HPLC-grade (99.8%) (May & Baker), methanol (99.5%) (Riedel-deHaen), glacial acetic
acid (99%) (Koch-Light), triethylamine (TEA) (99%) (Chambrian Chemicals) and tetrabutylammoniumhydrogen sulfate (TBAHS) (99%) (Fluka) were used. The active ingredients hydrochlorothiazide, enalapril
maleate, and the internal standard thiophylline were obtained from USP and BP as reference standards.
The water used was always distilled and deionized. Commercial tablets were purchased locally.

Chromatographic Conditions
The mobile phase consists of 3.0 mM TBAHS in ACN/H2 O/TEA (14 : 85.6 : 0.4 V/V) solution, and the pH
was adjusted to 4.1 by glacial acetic acid. The mobile phase was always filtered using 0.45 µm membrane
filters and was degassed by vacuum prior to use. The sample solutions were also filtered using 0.45 µm
membrane filters. The flow rate was 2 mL/min. The chart speed was 0.5 cm/min. The wavelength was 220
nm and the sensitivity was set at 0.08 AUFS.

Preparation of the standard solutions:
Internal standard solution: The internal standard solution was prepared by dissolving 200 mg of
theophylline in 1 L of 15% acetonitrile.
Standard solution for linearity: Standard stock solutions, containing 100 mg EM and 80 mg
HCT, were prepared in 50 mL of the internal standard solution. The following concentrations in the internal
standard solution were prepared by dilution: 0.1, 0.20, 0.30, 0.40, 0.50 and 0.60 mg/mL for EM and 0.08,
0.16, 0.24, 0.32, 0.48 and 0.54 for mg/mL for HCT.
Preparation of the sample solutions: Twenty tablets (1 tablet if content uniformity was to be
determined) were weighed and powdered. Accurately weighed portions of the powder (each equivalent to the
weight of 1 tablet) were placed in 50 mL volumetric flasks. Each sample was sonicated for 10 minutes with
30 mL of the internal standard solution. Samples were further diluted with the internal standard solution
to the required concentration. The solutions were filtered through 0.45 µm membrane filters.
50

Determination of Hydrochlorothiazide and Enalapril..., I. F. AL-MOMANI

Percent recovery study: This study was performed on synthetic mixtures identical to the pharmaceutical formulations. Synthetic mixtures were spiked with known amounts of EM and HCT spanning the
range 25-150% of the expected assay values. The resulting mixtures were assayed and the results obtained
were compared with the expected one.
Assay method: Equal volumes (10 µL) and approximately equal concentrations of standard and
sample solutions were injected into the HPLC and chromatographed under the conditions described above.
The standard and the sample solutions contained the same concentration of the internal standard. The
quantity of each component injected was always within the linearity range.

Results and Discussion
The chromatograms shown in Figure 1 indicate the possibility of separating HCT and EM using theophylline
as the internal standard. The chromatograms are free of interference from excipients normally used in tablet
formulation. No significant changes in sample retention and column efficiency were observed for a long
period of time (several months). The total elution time was less than 4 minutes.
To determine the linearity of the detector response, calibration standard solutions of HCT and EM
were prepared as described in the text. A plot of peak area ratio versus amount injected was found to be
linear in the range of 0.8-5.0 µg for HCT and 1.0-6.0 µg for EM with a correlation coefficient of 0.999 or
better. The detection limits based on a signal-to-noise ratio of 3 were 36 ng for HCT and 24 ng for EM as
determined by diluting the standard solutions and injecting 10 µL of each solution into the column.
The recovery of HCT and EM for synthetic mixtures was calculated using different concentrations for
each. The recoveries ranged from 101.5 to 97.9% for EM and 97.2 to 101.0 for HCT (Table 1). In all cases
excellent recoveries and reproducible results of the peak area were obtained. The selectivity of the method
is validated by the fact that no interference due to excipients was detected in the chromatograms produced
(Figure 1).

Table 1. Percent Recovery of HCT and EM From Spiked Placebo Samples

EM
mg added/T %Recovery∗
30.00
100.8±1.3
25.00
100.7±1.2
20.00
100.2±0.8
15.00
101.5±1.5
10.00
100.7±2.5
5.00
97.9±1.8
∗

HCT
mg added/T %Recovery∗
18.00
99.4±1.4
15.00
98.4±0.7
12.00
98.0±1.5
9.00
97.2±2.1
6.00
101.2±1.2
3.00
98.7±0.7

Mean ± RSD for 5 determinations.

The results of analysis of the commercial tablets (Table 2) indicate that the developed assay can be
used for the quantitation of HCT and EM in commercial tablets. The closeness of the results to the label
claim support the accuracy of the method. Replicate analysis of a single lot of angiozide tablets (n = 10)
on 3 days gave precision (expressed as the relative standard deviation) of less than 1.8% for both HCT and
EM, which support the precision of the method. The specificity of the method is further confirmed by the
results of the content uniformity test of HCT and EM, which was performed on commercial tablets (Table
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3). The results of content uniformity show compliance to the specificity of tablets and support the specificity
of this method.
a

b

c

III

I
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I
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Time (MIN)

Figure 1.
a) A typical chromatogram of a standard 10 µL injection containing 3.0 µg enalapril maleate (II, tR = 2.18 min),
5.0 µg hydrochlorothiazide (III, tR = 3.10 min) in the internal standard (I, tR = 1.56 min).
b) A chromatogram for 1 tablet of renitic drug in 50 mL internal standard.
c) A chromatogram for 1 tablet angiozide in 50 mL internal standard.

The validity of the method is further confirmed by analyzing 2 drugs (Angiozide and Renitec) for HCT
using the method described by Hitscherich et al.3. The mobile phase was a 15:85 mixture of CH3 : 0.05M
ammonium phosphate. According to the t- and F-tests, there were no significant differences between the
results obtained by the proposed method and the method described by Hitscherich at p = 0.05, demonstrating
that the proposed method is as accurate and precise as the reported methods.
A stability study was performed on pure HCT and EM powder by placing samples in dark bottles in a
glycerin-water bath at 70 ◦ C for 1 month. Samples were taken at 5-day intervals and assayed. No significant
loss in concentrations of HCT and EM was observed throughout the study.
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Table 2. Assay Results for HCT and EM in Commercial Tablets

Product
Angiozideb

Label Claim (mg/T)
HCT
EM
12.5
20

Reniticc

20

Vasereticd

10

a
b
c
d

Percent Found ± RSDa
HCT
EM
98.3±1.4
99.1±1.3
101.2±1.8
100.5±1.6
97.8±2.3
98.4±1.9
100.4±1.5
100.2±1.2
100.1±0.6
99.7±0.8
101.9±2.9
102.7±0.8

Meant ± RSD for 5 determinations.
Lot 950612 (The Jordanian Pharm. Manufacturing Co. LTD., Naor, Jordan).
Lot 313990 L (Merk Sharp & Dohm, Haarlem-Netherlands).
Lot R8502 (Merk Sharp & Dohm, Haarlem-Netherlands).
Table 3. Content Uniformity in Commercial Productsa

Tablet No.

1
2
3
4
5
6
7
8
9
10
Mean
RSD
a

Percent Label Claim Found
Renitic Tablets Angiozide Tablets Vaseretic Tablets
EM
EM
HCT
EM
98.9
98.2
97.8
100.0
100.1
101.6
100.6
96.7
100.3
102.4
101.2
99.3
97.0
98.8
98.9
99.6
100.2
102.4
103.6
101.8
99.9
101.9
101.3
99.8
100.2
99.7
101.8
101.3
100.2
98.3
97.1
101.5
99.7
101.8
101.1
97.6
100.3
102.0
102.2
101.5
99.7
100.7
100.6
99.9
1.02
1.7
2.0
1.7

The same lots indicated in Table 2.

In conclusion, the HPLC assay described here has been shown to be accurate, precise, rapid, and
easy to perform. In addition, the proposed method can be applied to the quality control analysis of EM
either alone or in combination with HCT without interferences from the additives and excipients normally
used in tablet formulations. The method was successfully applied to analyze EM and HCT in commercially
available products.
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